Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-26 @ 6:46 PM
Study NCT ID:
NCT07020260
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-13
First Post:
2025-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies
Sponsor:
Princess Maxima Center for Pediatric Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-26
First Submit QC Date:
None
Study First Post Date:
2025-06-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-05
Last Update Post Date:
2025-06-13
Last Update Post Date Type:
ACTUAL